Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1395

1.

Bronchiectasis: a case-based approach to investigation and management.

Contarini M, Finch S, Chalmers JD.

Eur Respir Rev. 2018 Jul 11;27(149). pii: 180016. doi: 10.1183/16000617.0016-2018. Print 2018 Sep 30. Review.

2.

Burden and Risk Factors for Pseudomonas aeruginosa Community-acquired Pneumonia: a Multinational Point Prevalence Study of Hospitalised Patients.

Restrepo MI, Babu BL, Reyes LF, Chalmers JD, Soni NJ, Sibila O, Faverio P, Cilloniz C, Rodriguez-Cintron W, Aliberti S.

Eur Respir J. 2018 Jul 5. pii: 1701190. doi: 10.1183/13993003.01190-2017. [Epub ahead of print]

PMID:
29976651
3.

Relationship Between Plasma 8-OH-Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial.

Thomas MC, Woodward M, Li Q, Pickering R, Tikellis C, Poulter N, Cooper ME, Marre M, Zoungas S, Chalmers J; ADVANCE Collaborative Group.

J Am Heart Assoc. 2018 Jun 30;7(13). pii: e008226. doi: 10.1161/JAHA.117.008226.

4.

The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation. A case-crossover analysis.

Goeminne CP, Cox B, Finch S, Loebinger MR, Bedi P, Hill AT, Fardon TC, de Hoogh K, Nawrot TS, Chalmers JD.

Eur Respir J. 2018 Jun 14. pii: 1702557. doi: 10.1183/13993003.02557-2017. [Epub ahead of print]

PMID:
29903857
5.

IMMUNOLOGICAL COROLLARY OF THE PULMONARY MYCOBIOME IN BRONCHIECTASIS: THE CAMEB STUDY.

Mac Aogáin M, Chandrasekaran R, Lim Yick Hou A, Teck Boon L, Liang Tan G, Hassan T, Thun How O, Hui Qi Ng A, Bertrand D, Yu Koh J, Lei Pang S, Yang Lee Z, Wei Gwee X, Martinus C, Yie Sio Y, Anusha Matta S, Tim Chew F, Keir HR, Connolly JE, Arputhan Abisheganaden J, Siyue Koh M, Nagarajan N, Chalmers JD, Chotirmall SH.

Eur Respir J. 2018 Jun 7. pii: 1800766. doi: 10.1183/13993003.00766-2018. [Epub ahead of print]

PMID:
29880655
6.

Severe Paediatric Asthma Collaborative in Europe (SPACE): protocol for a European registry.

Liu NM, van Aalderen W, Carlsen KCL, Coleman C, Chalmers JD, Cunningham S, Fernandes RM, Fleming LJ, Gappa M, Karadag B, Midulla F, Pijnenburg MWH, Rutjes NW, Rusconi F, Grigg J.

Breathe (Sheff). 2018 Jun;14(2):93-98. doi: 10.1183/20734735.002018. Review.

7.

Occupational heat exposure among municipal workers.

Uejio CK, Morano LH, Jung J, Kintziger K, Jagger M, Chalmers J, Holmes T.

Int Arch Occup Environ Health. 2018 Aug;91(6):705-715. doi: 10.1007/s00420-018-1318-3. Epub 2018 Jun 5.

PMID:
29869703
8.

Continuous versus intermittent antibiotics for bronchiectasis.

Donovan T, Felix LM, Chalmers JD, Milan SJ, Mathioudakis AG, Spencer S.

Cochrane Database Syst Rev. 2018 Jun 3;6:CD012733. doi: 10.1002/14651858.CD012733.pub2. Review.

PMID:
29860722
9.

The effects of a lifestyle-focused text-messaging intervention on adherence to dietary guideline recommendations in patients with coronary heart disease: an analysis of the TEXT ME study.

Santo K, Hyun K, de Keizer L, Thiagalingam A, Hillis GS, Chalmers J, Redfern J, Chow CK.

Int J Behav Nutr Phys Act. 2018 May 23;15(1):45. doi: 10.1186/s12966-018-0677-1.

10.

"The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study.

Dudgeon EK, Crichton M, Chalmers JD.

BMC Pulm Med. 2018 May 22;18(1):81. doi: 10.1186/s12890-018-0631-7.

11.

Bronchiectasis: an emerging global epidemic.

Chotirmall SH, Chalmers JD.

BMC Pulm Med. 2018 May 22;18(1):76. doi: 10.1186/s12890-018-0629-1.

12.

Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.

Chandrasekaran R, Mac Aogáin M, Chalmers JD, Elborn SJ, Chotirmall SH.

BMC Pulm Med. 2018 May 22;18(1):83. doi: 10.1186/s12890-018-0638-0. Review.

13.

Clinical Utility of Electronic Alberta Stroke Program Early Computed Tomography Score Software in the ENCHANTED Trial Database.

Nagel S, Wang X, Carcel C, Robinson T, Lindley RI, Chalmers J, Anderson CS; ENCHANTED Investigators.

Stroke. 2018 Jun;49(6):1407-1411. doi: 10.1161/STROKEAHA.117.019863. Epub 2018 May 18.

PMID:
29777016
14.

Predicting outcomes in bronchiectasis.

Mendes MA, Chalmers JD.

Pulmonology. 2018 May - Jun;24(3):146-148. doi: 10.1016/j.pulmoe.2018.04.004. No abstract available.

15.

Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative.

Grinich EE, Schmitt J, Küster D, Spuls PI, Williams HC, Chalmers JR, Thomas KS, Apfelbacher C, Prinsen CAC, Furue M, Stuart B, Carter B, Simpson EL.

Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16732. [Epub ahead of print] No abstract available.

PMID:
29747242
16.

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial.

Welsh P, Rankin N, Li Q, Mark PB, Würtz P, Ala-Korpela M, Marre M, Poulter N, Hamet P, Chalmers J, Woodward M, Sattar N.

Diabetologia. 2018 Jul;61(7):1581-1591. doi: 10.1007/s00125-018-4619-x. Epub 2018 May 4.

PMID:
29728717
17.

Lipid-Lowering Pretreatment and Outcome Following Intravenous Thrombolysis for Acute Ischaemic Stroke: A Post Hoc Analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study Trial.

Minhas JS, Wang X, Arima H, Bath PM, Billot L, Broderick JP, Donnan GA, Kim JS, Lavados PM, Lee TH, Martins SCO, Olavarría VV, Pandian JD, Pontes-Neto OM, Ricci S, Sato S, Sharma VK, Thang NH, Wang JG, Woodward M, Chalmers J, Anderson CS, Robinson TG; ENCHANTED Investigators.

Cerebrovasc Dis. 2018 Apr 27;45(5-6):213-220. doi: 10.1159/000488911. [Epub ahead of print]

PMID:
29705803
18.

Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative).

Chalmers JR, Thomas KS, Apfelbacher C, Williams HC, Prinsen CA, Spuls PI, Simpson E, Gerbens LAA, Boers M, Barbarot S, Stalder JF, Abuabara K, Aoki V, Ardeleanu M, Armstrong J, Bang B, Berents TL, Burton T, Butler L, Chubachi T, Cresswell-Melville A, DeLozier A, Eckert L, Eichenfield L, Flohr C, Futamura M, Gadkari A, Gjerde ES, van Halewijn KF, Hawkes C, Howells L, Howie L, Humphreys R, Ishii HA, Kataoka Y, Katayama I, Kouwenhoven W, Langan SM, Leshem YA, Merhand S, Mina-Osorio P, Murota H, Nakahara T, Nunes FP, Nygaard U, Nygårdas M, Ohya Y, Ono E, Rehbinder E, Rogers NK, Romeijn GLE, Schuttelaar MLA, Sears AV, Simpson MA, Singh JA, Srour J, Stuart B, Svensson Å, Talmo G, Talmo H, Teixeira HD, Thyssen JP, Todd G, Torchet F, Volke A, von Kobyletzki L, Weisshaar E, Wollenberg A, Zaniboni M.

Br J Dermatol. 2018 May;178(5):e332-e341. doi: 10.1111/bjd.16543. Epub 2018 Apr 19.

PMID:
29672835
20.

More on Low-Dose versus Standard-Dose Intravenous Alteplase in Acute Ischemic Stroke.

Anderson CS, Woodward M, Chalmers J.

N Engl J Med. 2018 Apr 12;378(15):1465-1466. doi: 10.1056/NEJMc1801548. No abstract available.

21.

Insulin-like growth factor binding protein-4 inhibits epithelial growth and proliferation in the rodent intestine.

Austin K, Tsang D, Chalmers JA, Maalouf MF, Brubaker PL.

Am J Physiol Gastrointest Liver Physiol. 2018 Apr 6. doi: 10.1152/ajpgi.00349.2017. [Epub ahead of print]

PMID:
29631376
22.

Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial.

Haines RH, Thomas KS, Montgomery AA, Ravenscroft JC, Akram P, Chalmers JR, Whitham D, Duley L, Eleftheriadou V, Meakin G, Mitchell EJ, White J, Rogers A, Sach T, Santer M, Tan W, Hepburn T, Williams HC, Batchelor J.

BMJ Open. 2018 Apr 3;8(4):e018649. doi: 10.1136/bmjopen-2017-018649.

23.

Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review.

Torres A, Cillóniz C, Blasi F, Chalmers JD, Gaillat J, Dartois N, Schmitt HJ, Welte T.

Respir Med. 2018 Apr;137:6-13. doi: 10.1016/j.rmed.2018.02.007. Epub 2018 Feb 19. Review.

PMID:
29605214
24.

Use of the waist-to-height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE-ON study.

Rådholm K, Chalmers J, Ohkuma T, Peters S, Poulter N, Hamet P, Harrap S, Woodward M.

Diabetes Obes Metab. 2018 Aug;20(8):1903-1910. doi: 10.1111/dom.13311. Epub 2018 May 6.

PMID:
29603537
25.

Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges.

Lustberg MB, Stover DG, Chalmers JJ.

Cancer J. 2018 Mar/Apr;24(2):61-64. doi: 10.1097/PPO.0000000000000309.

PMID:
29601331
26.

Current status of intravenous tissue plasminogen activator dosage for acute ischaemic stroke: an updated systematic review.

Wang X, You S, Sato S, Yang J, Carcel C, Zheng D, Yoshimura S, Anderson CS, Sandset EC, Robinson T, Chalmers J, Sharma VK.

Stroke Vasc Neurol. 2018 Jan 13;3(1):28-33. doi: 10.1136/svn-2017-000112. eCollection 2018 Mar.

27.

Correction: Clinical applications of infrared and Raman spectroscopy: state of play and future challenges.

Baker MJ, Byrne HJ, Chalmers J, Gardner P, Goodacre R, Henderson A, Kazarian SG, Martin FL, Moger J, Stone N, Sulé-Suso J.

Analyst. 2018 Apr 16;143(8):1934. doi: 10.1039/c8an90029a.

PMID:
29595198
28.

Oral versus inhaled antibiotics for bronchiectasis.

Spencer S, Felix LM, Milan SJ, Normansell R, Goeminne PC, Chalmers JD, Donovan T.

Cochrane Database Syst Rev. 2018 Mar 27;3:CD012579. doi: 10.1002/14651858.CD012579.pub2. Review.

PMID:
29587336
29.

Pharmacy informatics in multihospital health systems: Opportunities and challenges.

Chalmers J, Siska M, Le T, Knoer S.

Am J Health Syst Pharm. 2018 Apr 1;75(7):457-464. doi: 10.2146/ajhp170580.

PMID:
29572314
30.

Comparative effects of low-dose versus standard-dose alteplase in ischemic patients with prior stroke and/or diabetes mellitus: The ENCHANTED trial.

Chen G, Wang X, Robinson TG, Pikkemaat M, Lindley RI, Zhou S, Ping L, Liu W, Liu L, Chalmers J, Anderson CS; ENCHANTED Investigators.

J Neurol Sci. 2018 Apr 15;387:1-5. doi: 10.1016/j.jns.2018.01.014. Epub 2018 Jan 11.

PMID:
29571842
31.

The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.

Wai DCC, Szyszka TN, Campbell AE, Kwong C, Wilkinson-White LE, Silva APG, Low JKK, Kwan AH, Gamsjaeger R, Chalmers JD, Patrick WM, Lu B, Vakoc CR, Blobel GA, Mackay JP.

J Biol Chem. 2018 May 11;293(19):7160-7175. doi: 10.1074/jbc.RA117.000678. Epub 2018 Mar 22.

PMID:
29567837
32.

Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data.

Karmali KN, Lloyd-Jones DM, van der Leeuw J, Goff DC Jr, Yusuf S, Zanchetti A, Glasziou P, Jackson R, Woodward M, Rodgers A, Neal BC, Berge E, Teo K, Davis BR, Chalmers J, Pepine C, Rahimi K, Sundström J; Blood Pressure Lowering Treatment Trialists’ Collaboration.

PLoS Med. 2018 Mar 20;15(3):e1002538. doi: 10.1371/journal.pmed.1002538. eCollection 2018 Mar.

33.

The Elusive Hunt for a Reliable Biomarker in Community-acquired Pneumonia: Are We Searching for Something that Can't Exist?

Waterer G, Chalmers J.

Am J Respir Crit Care Med. 2018 Mar 20. doi: 10.1164/rccm.201803-0462ED. [Epub ahead of print] No abstract available.

PMID:
29558164
34.

Macrolide antibiotics for bronchiectasis.

Kelly C, Chalmers JD, Crossingham I, Relph N, Felix LM, Evans DJ, Milan SJ, Spencer S.

Cochrane Database Syst Rev. 2018 Mar 15;3:CD012406. doi: 10.1002/14651858.CD012406.pub2. Review.

PMID:
29543980
35.

Clinical applications of infrared and Raman spectroscopy: state of play and future challenges.

Baker MJ, Byrne HJ, Chalmers J, Gardner P, Goodacre R, Henderson A, Kazarian SG, Martin FL, Moger J, Stone N, Sulé-Suso J.

Analyst. 2018 Apr 16;143(8):1735-1757. doi: 10.1039/c7an01871a. Review. Erratum in: Analyst. 2018 Mar 29;:.

PMID:
29504623
36.

Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.

Suarez-Cuartin G, Giner J, Merino JL, Rodrigo-Troyano A, Feliu A, Perea L, Sanchez-Reus F, Castillo D, Plaza V, Chalmers JD, Sibila O.

Respir Med. 2018 Mar;136:111-117. doi: 10.1016/j.rmed.2018.02.008. Epub 2018 Feb 13.

PMID:
29501241
37.

Bronchiectasis Exacerbations Are Heart-Breaking.

Chalmers JD.

Ann Am Thorac Soc. 2018 Mar;15(3):301-303. doi: 10.1513/AnnalsATS.201710-832ED. No abstract available.

PMID:
29493334
38.

Bronchiectasis: new therapies and new perspectives.

Chalmers JD, Chotirmall SH.

Lancet Respir Med. 2018 Feb 22. pii: S2213-2600(18)30053-5. doi: 10.1016/S2213-2600(18)30053-5. [Epub ahead of print] Review.

PMID:
29478908
39.

Continuous, intrinsic magnetic depletion of erythrocytes from whole blood with a quadrupole magnet and annular flow channel; pilot scale study.

Moore LR, Mizutani D, Tanaka T, Buck A, Yazer M, Zborowski M, Chalmers JJ.

Biotechnol Bioeng. 2018 Jun;115(6):1521-1530. doi: 10.1002/bit.26581. Epub 2018 Mar 13.

PMID:
29476625
40.

Rebuttal From Dr Chalmers.

Chalmers JD.

Chest. 2018 Apr;153(4):785-786. doi: 10.1016/j.chest.2018.01.036. Epub 2018 Feb 21. No abstract available.

PMID:
29474808
41.

POINT: Should an Attempt Be Made to Withdraw Inhaled Corticosteroids in All Patients With Stable GOLD 3 (30% ≤ FEV1 < 50% Predicted) COPD? Yes.

Chalmers JD.

Chest. 2018 Apr;153(4):778-782. doi: 10.1016/j.chest.2018.01.029. Epub 2018 Feb 21. No abstract available.

PMID:
29474807
42.

Genetic mutations associated with lung cancer metastasis to the brain.

Aljohani HM, Aittaleb M, Furgason JM, Amaya P, Deeb A, Chalmers JJ, Bahassi EM.

Mutagenesis. 2018 Apr 13;33(2):137-145. doi: 10.1093/mutage/gey003.

PMID:
29474635
43.

Response to Comment on Ohkuma et al. Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial. Diabetes Care 2017;40:1203-1209.

Ohkuma T, Woodward M, Chalmers J; ADVANCE Collaborative Group.

Diabetes Care. 2018 Mar;41(3):e39. doi: 10.2337/dci17-0060. No abstract available.

PMID:
29463676
44.

Core outcome sets in dermatology: report from the second meeting of the International Cochrane Skin Group Core Outcome Set Initiative.

Kottner J, Jacobi L, Hahnel E, Alam M, Balzer K, Beeckman D, Busard C, Chalmers J, Deckert S, Eleftheriadou V, Furlan K, Horbach SER, Kirkham J, Nast A, Spuls P, Thiboutot D, Thorlacius L, Weller K, Williams HC, Schmitt J; International Cochrane Skin Group Core Outcome Set Initiative (CSG-COUSIN) group.

Br J Dermatol. 2018 Apr;178(4):e279-e285. doi: 10.1111/bjd.16324. Epub 2018 Feb 14.

PMID:
29441525
45.

Low- versus Standard-Dose Intravenous Alteplase in the Context of Bridging Therapy for Acute Ischemic Stroke: A Korean ENCHANTED Study.

Kim JS, Kim YJ, Lee KB, Cha JK, Park JM, Hwang Y, Kim EG, Rha JH, Koo J, Kim J, Kim YJ, Seo WK, Kim DE, Robinson TG, Lindley RI, Wang X, Chalmers J, Anderson CS.

J Stroke. 2018 Jan;20(1):131-139. doi: 10.5853/jos.2017.01578. Epub 2018 Jan 31.

46.

Salt intake and dietary sources of salt on weekdays and weekend days in Australian adults.

Nowson C, Lim K, Land MA, Webster J, Shaw JE, Chalmers J, Flood V, Woodward M, Grimes C.

Public Health Nutr. 2018 Feb 1:1-9. doi: 10.1017/S1368980017004104. [Epub ahead of print]

PMID:
29388516
47.

The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis.

Araújo D, Shteinberg M, Aliberti S, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Stone G, Trautmann M, Davis A, Dimakou K, Polverino E, De Soyza A, McDonnell MJ, Chalmers JD.

Eur Respir J. 2018 Jan 31;51(2). pii: 1701953. doi: 10.1183/13993003.01953-2017. Print 2018 Feb.

PMID:
29386336
48.

RESPIRE: breathing new life into bronchiectasis.

Chotirmall SH, Chalmers JD.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702444. doi: 10.1183/13993003.02444-2017. Print 2018 Jan. No abstract available.

PMID:
29371393
49.

Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis.

Chalmers JD, Aliberti S, Filonenko A, Shteinberg M, Goeminne PC, Hill AT, Fardon TC, Obradovic D, Gerlinger C, Sotgiu G, Operschall E, Rutherford RM, Dimakou K, Polverino E, De Soyza A, McDonnell MJ.

Am J Respir Crit Care Med. 2018 Jun 1;197(11):1410-1420. doi: 10.1164/rccm.201711-2202OC.

PMID:
29357265
50.

How should minimally important change scores for the Patient-Oriented Eczema Measure be interpreted? A validation using varied methods.

Howells L, Ratib S, Chalmers JR, Bradshaw L, Thomas KS; CLOTHES trial team.

Br J Dermatol. 2018 May;178(5):1135-1142. doi: 10.1111/bjd.16367. Epub 2018 Apr 17.

Supplemental Content

Loading ...
Support Center